Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs, Symlin (pramlintide acetate) and Byetta (exenatide) and Bydureon (exenatide extended-release). Amylin also is working on producing analog of human leptin... More

Business

Revenue:

Currency Amount Valid Date
  • 840,110,000
  • Dec 31, 2008
  • 510,900,000
  • Dec 31, 2006
View entire collection »

Operating Income:

Currency Amount Valid Date
  • -297,220,000
  • Dec 31, 2008
  • -28,610,000
  • Dec 31, 2006
View entire collection »

Net profit:

Currency Amount Valid Date
  • -315,400,000
  • Dec 31, 2008

Cash:

Currency Amount Valid Date
  • 237,260,000
  • Dec 31, 2008

Current Assets:

Currency Amount Valid Date
  • 1,036,070,000
  • Dec 31, 2008

Total Assets:

Currency Amount Valid Date
  • 1,712,630,000
  • Dec 31, 2008

Current Liabilities:

Currency Amount Valid Date
  • 313,780,000
  • Dec 31, 2008

Total Liabilities:

Currency Amount Valid Date
  • 1,361,760,000
  • Dec 31, 2008

Retained Earnings:

Currency Amount Valid Date
  • -1,749,720,000
  • Dec 31, 2008

Competitive space:

Space Brand
top ↑

Organization

Address

Amylin Pharmaceuticals Headquarters

9360 TOWNE CENTRE DR
San Diego California 92121

Amylin Pharmaceuticals Headquarters

9360 TOWNE CENTRE DR
San Diego California 92121

Leadership:

Person Title
  • Sr VP Legal & Corp Affairs & G
  • VP Sales
  • Sr VP Corporate Development
  • Sr VP Finance & CFO
View entire collection »
top ↑ top ↑

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!